The first Swedish case of familial amyloidotic polyneuropathy (FAP) was published in 1965. The same transthyretin (TTR met30) mutation as that seen in Japanese, Portuguese, and other populations was also found in Swedish FAP patients. More than 350 patients with clinical manifestations of FAP have been diagnosed in northern Sweden, most of them originating from the areas around SkellefteA and PiteA. The mean age of onset is 56 years, much later than in patients from Japan and Portugal. To estimate the frequency of the TTR met30 mutation in the counties of Vasterbotten and Norrbotten, sera from 1276 persons aged 24 to 65 years, randomly sampled from a health programme (MONICA), were screened with the monoclonal antibody FD6. In 19 persons, 13 females and six males, a positive reaction was seen in an Elisa test using this antibody. DNA analysis confirmed the TTR met30 mutation and showed that 18 were heterozygous and one homozygous for this mutation. Other mutations were not looked for in this study. The mean TTR met30 carrier frequency in the area was 1.5% ranging from 0 0 to 8-3% in 23 subpopulations. There was a notable discrepancy between the regional distribution of the TTR met30 allele and the morbidity rate for FAP. The estimated number of TTR met'0 gene carriers in a total population of 500 000 in the area is approximately 7500. The penetrance of the TTR met'4 mutation shows considerable variation between families, and the overall diagnostic (predictive) value in this population is as low as around 2%.
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(J Med Genet 1994;31:351-354)
Amyloidosis comprises a group of diseases associated with the deposition of amyloid substance in various tissues of the body. All amyloid is built up by fine fibrils which are polymers of low molecular weight proteips in 3 pleated sheet conformation. ' In the present investigation, the frequency of TTR met30 carriers was studied in the two northernmost counties of Sweden by examining 1286 unselected healthy subjects with a monoclonal antibody and the Elisa technique. 405 nm after 30 minutes. The test is semiquantitative and the positive samples show a strong green colour. All samples were tested in duplicate and positive and negative controls were included. Results were standardised on positive controls after subtraction of the negative control.
Results and discussion In 19 subjects, 13 females and six males, a positive reaction was seen with the Elisa (table  2) . DNA analysis using PCR and cleavage with NsiI showed that 18 were heterozygous and one homozygous for the TTR met30 mutation. Other mutations were not looked for in this study. The figure shows the regional distribution of living patients and TTR met30 carriers in northern Sweden using a distribution into 23 regions which has been used in several previous population genetic and epidemiological studies. Northern Sweden shows marked ethnic heterogeneity with a strong Finnish influence in the northern and north eastern parts, whereas the strongest Saami (Lapp) influence has been found in the northern and north western parts. From the geographical pattern of variation of the TTR met30 allele it appears that there is no evident correlation with Finnish or Saamish influence.
The mean frequency of TTR met30 carriers in northern Sweden was 1-5% with a range of 0 0 to 8-3 between subpopulations. Using the average figure of 1-5% the number of carriers in the total population of about 500 000 inhabitants can be estimated to be approximately 7500.
Since the number of carriers was small, the data from the 23 regions were aggregated into six areas (figure), two inland and four in the coastal region, and subjected to analysis of heterogeneity. In this analysis the homozygote was counted as one carrier. There was a significant heterogeneity between the six areas (p <0001). It is notable that the frequency of carriers was not particularly high in Skelleftea (region 8) where most FAP patients have been previously diagnosed. There was, for example, a significantly higher frequency of carriers in the Pitea region (region 18) compared to the Skelleftea region (p < 0 025) in spite of the fact that the prevalence of FAP has been found to be lower in the Pitea region.20 A relatively low carrier frequency (2-0%) was found also in a previous investigation in the Skelleftea area. 8 The high gene frequency in the Pitea region is in agreement with the fact that six homozygotes have previously been found.891' In the Skelleftea region one homozygote has been found." Quite a high frequency (two heterozygotes and one homozygote out of 36 persons) was also found in the inland Lycksele region (region 5). The difference between the Lycksele and Skelleftea regions was statistically significant (p < 0 05) The number of diagnosed FAP patients in the Lycksele region is quite low, the age of onset is usually late, and the clinical course relatively mild.
It is obvious that in northern Sweden there is a discrepancy between the geographical distribution of the TTR met'0 allele predisposing to FAP and the numbers of FAP patients (figure). The number of patients alive in northern Sweden at the time of this study is 152 which gives a prevalence of 0-00031. With an overall carrier frequency of 0 015 the predictive (diagnostic) value can be estimated to be about 2%. However, earlier pedigree analyses have shown that the penetrance in some families may approach 50%. 21 This strongly contrasts with the findings in the Portuguese FAP population where the gene penetrance is generally considered to be higher.
In the Swedish material there may be a number of undiagnosed patients with very late onset and slight symptoms. Though increased awareness of FAP may influence the prevalence rate, it seems unlikely that the discrepancy between carrier frequencies and prevalence rates seen in this study can be explained by increased awareness only. It is more likely that some hitherto unknown factor in the Skellefte'a subpopulation is responsible for the accumulation of FAP in this region.
